D
Spero Therapeutics, Inc. SPRO
$1.87 $0.010.54% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income -53.60M -69.76M -68.57M 3.51M 17.46M
Total Depreciation and Amortization 0.00 2.00K 2.00K 40.00K 148.00K
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 7.01M 8.39M 8.84M 9.31M 14.35M
Change in Net Operating Assets 14.26M 27.99M 36.28M -30.40M -46.34M
Cash from Operations -32.33M -33.38M -23.44M -17.54M -14.38M
Capital Expenditure -- -- -- -- --
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -- -- -- -- --
Cash from Investing -- -- -- -- --
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock -- -- -- 1.00K 221.00K
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash from Financing -- -- -- 1.00K 221.00K
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash -32.33M -33.38M -23.44M -17.54M -14.16M